Takanori Kigawa

Dr. Takanori Kigawa

RIKEN Center for Biosystems Dynamics Research (BDR) 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Trends in Plant Science
Verified
Journal Article
Closed access
KYKazuhiko Yamasaki
Kazuhiko Yamasaki
TKTakanori Kigawa
Takanori Kigawa
MSMotoaki Seki
Motoaki Seki
KSKazuo Shinozaki
Kazuo Shinozaki
SYShigeyuki Yokoyama
Shigeyuki Yokoyama

1 August 1996 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
DKDong-myung Kim
Dong-myung Kim
TKTakanori Kigawa
Takanori Kigawa
CCCha‐Yong Choi
Cha‐Yong Choi
SYShigeyuki Yokoyama
Shigeyuki Yokoyama
We modified a cell‐free coupled transcription/translation system from Escherichia coli with the T7 phage RNA polymerase, and achieved a productivity as high as 0.4 mg protein/ml reaction mixture. First, we found that the optimal concentrations of phosphoenolpyruvate and poly(ethylene glycol) are interdependent; higher concentrations of the former should be used at higher concentrations of the latter. Second, the use of a condensed 30000×g cell extract, in place of the conventional one, significantly increased the initial rate of protein synthesis. This phenomenon was demonstrated to be due to a reason other than elimination of inhibitory molecule(s) from the extract. For this system with the condensed extract, the phosphoenolpyruvate and poly(ethylene glycol) concentrations were again co‐optimized, resulting in production of chloramphenicol acetyltransferase at a productivity of 0.3 mg/ml. Finally, the productivity was further increased up to 0.4 mg/ml, by supplementation of the pool of amino acids. This improved cell‐free protein synthesis system is superior in productivity to any other cell‐free systems.

5 August 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TYTakashi Yaeno
Takashi Yaeno
HLHua Li
Hua Li
ACAngela Chaparro-Garcia
Angela Chaparro-Garcia
SSSebastian Schornack
Sebastian Schornack
SKSeizo Koshiba
Seizo Koshiba
KSKen Shirasu
Ken Shirasu
The oomycete pathogen Phytophthora infestans causes potato late blight, one of the most economically damaging plant diseases worldwide. P. infestans produces AVR3a, an essential modular virulence effector with an N-terminal RXLR domain that is required for host-cell entry. In host cells, AVR3a stabilizes and inhibits the function of the E3 ubiquitin ligase CMPG1, a key factor in host immune responses including cell death triggered by the pathogen-derived elicitor protein INF1 elicitin. To elucidate the molecular basis of AVR3a effector function, we determined the structure of Phytophthora capsici AVR3a4, a close homolog of P. infestans AVR3a. Our structural and functional analyses reveal that the effector domain of AVR3a contains a conserved, positively charged patch and that this region, rather than the RXLR domain, is required for binding to phosphatidylinositol monophosphates (PIPs) in vitro. Mutations affecting PIP binding do not abolish AVR3a recognition by the resistance protein R3a but reduce its ability to suppress INF1-triggered cell death in planta. Similarly, stabilization of CMPG1 in planta is diminished by these mutations. The steady-state levels of non–PIP-binding mutant proteins in planta are reduced greatly, although these proteins are stable in vitro. Furthermore, overexpression of a phosphatidylinositol phosphate 5-kinase results in reduction of AVR3a levels in planta. Our results suggest that the PIP-binding ability of the AVR3a effector domain is essential for its accumulation inside host cells to suppress CMPG1-dependent immunity.

1 September 1995 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
TKTakanori Kigawa
Takanori Kigawa
YMYutaka Muto
Yutaka Muto
SYShigeyuki Yokoyama
Shigeyuki Yokoyama

15 October 2009 in Journal of Virology
Verified
Journal Article
Open access
PDF file
FDFelipe Diaz-Griffero
Felipe Diaz-Griffero
XQXu-Rong Qin
Xu-Rong Qin
FHFumiaki Hayashi
Fumiaki Hayashi
TKTakanori Kigawa
Takanori Kigawa
AFAndrés Finzi
Andrés Finzi
JSJoseph Sodroski
Joseph Sodroski
TRIM5α is a tripartite motif (TRIM) protein that consists of RING, B-box 2, coiled-coil, and B30.2(SPRY) domains. The TRIM5α rh protein from rhesus monkeys recognizes the human immunodeficiency virus type 1 (HIV-1) capsid as it enters the host cell and blocks virus infection prior to reverse transcription. HIV-1-restricting ability can be eliminated by disruption of the B-box 2 domain. Changes in the TRIM5α rh B-box 2 domain have been associated with alterations in TRIM5α rh turnover, the formation of cytoplasmic bodies and higher-order oligomerization. We present here the nuclear magnetic resonance structure of the TRIM5 B-box 2 domain and identify an unusual hydrophobic patch (cluster 1) on the domain surface. Alteration of cluster 1 or the flanking arginine 121 resulted in various degrees of inactivation of HIV-1 restriction, in some cases depending on compensatory changes in other nearby charged residues. For this panel of TRIM5α rh B-box 2 mutants, inhibition of HIV-1 infection was strongly correlated with higher-order self-association and binding affinity for capsid complexes but not with TRIM5α rh half-life or the formation of cytoplasmic bodies. Thus, promoting cooperative TRIM5α rh interactions with the HIV-1 capsid represents a major mechanism whereby the B-box 2 domain potentiates HIV-1 restriction.

1 September 2010 in Structure
Verified
Journal Article
Closed access
FHFahu He
Fahu He
Takashi UmeharaTakashi Umehara
Takashi Umehara
KSKohei Saito
Kohei Saito
THTakushi Harada
Takushi Harada
SWSatoru Watanabe
Satoru Watanabe
YMYutaka Muto
Yutaka Muto